GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (OTCPK:TRJNF) » Definitions » Current Accrued Expense

TRJNF (Trajan Group Holdings) Current Accrued Expense : $0.0 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Trajan Group Holdings Current Accrued Expense?

Trajan Group Holdings's Current Accrued Expense for the quarter that ended in Jun. 2024 was $0.0 Mil.


Trajan Group Holdings Current Accrued Expense Historical Data

The historical data trend for Trajan Group Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trajan Group Holdings Current Accrued Expense Chart

Trajan Group Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Current Accrued Expense
- - - -

Trajan Group Holdings Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Current Accrued Expense Get a 7-Day Free Trial - - - - -

Trajan Group Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Trajan Group Holdings Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Trajan Group Holdings's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Trajan Group Holdings Business Description

Traded in Other Exchanges
Address
7 Argent Place, Ringwood, VIC, AUS, 3134
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental sample. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and Consumables that includes parts, supplies, components and consumable products across the world. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).